Accessibility Menu
Asp Isotopes logo

Asp Isotopes(NASDAQ) ASPI

Market Cap$605.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+48%
5 YearN/A
1 Year-56%
1 Month-7%
Premium Feature
Moneyball Superscore
47/100
$3.95
-3.55%
-0.14Today
Pre market$3.99+$0.05 (+1.14%)
Asp Isotopes last closing stock price
MetricPriceDate
Last closeUSD 3.952026-08-20
Asp Isotopes stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.71%USD 4.282026-08-13
1 month-7.28%USD 4.262026-07-21
3 month-28.83%USD 5.552026-05-22
Year to date-26.17%USD 5.352025-12-31
1 year-55.96%USD 8.972025-08-20
3 year+246.49%USD 1.142023-08-21
Since inception+47.94%USD 2.672022-11-10

Asp Isotopes Financials at a Glance

Market Cap

$605.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$30.85M

Net Income (TTM)

-$132.05M

EPS (TTM)

-$1.32

P/E Ratio

-3.00

Dividend

$0.00

Beta (Volatility)

2.58 (High)

Price

$3.95

Volume

2,377.333

Open

$4.16

Previous Close

$3.95

Daily Range

$3.87 - $4.16

52-Week Range

$3.51 - $14.49

Estimated Earnings Date

Nov 12, 2026

ASPI News

No articles available.

ASPI: Motley Fool Moneyball Superscore

47

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Asp Isotopes

ASP Isotopes Inc. makes rare materials for healthcare and energy. It provides specialized atoms used in medical scans and semiconductors. These products help advance cancer treatments and cleaner nuclear power.

Separating Atoms for the World

  • Specialist Isotopes: High-value materials like Carbon-14 and Silicon-28 for medical research; generated $3.9 million for the three months ended June 30, 2026.
  • Nuclear Fuels: Components like high-assay low-enriched uranium for advanced reactors; produced $0.6 million in revenue in the second quarter of 2026.
  • Helium and LNG: Production of liquid natural gas and helium; recorded $0.7 million in revenue for the three months ended June 30, 2026.
  • Radiopharmaceuticals: Sale of medical doses used in specialized diagnostic scans through companies like PET Labs and Numed.

Growing Through Strategic Deals

  • Acquired Renergen in January 2026 to add liquid natural gas and helium production in South Africa to its portfolio.
  • Purchased East Coast Nuclear Pharmacy in October 2025 to expand the distribution of medical isotopes.
  • Partnered with TerraPower in May 2025 to fund the construction of a new uranium enrichment facility.
  • Took a 60% stake in Numed in January 2026 to increase its radiopharmaceutical production capabilities.

Unique Tech for Rare Materials

The company uses two proprietary enrichment processes to produce isotopes that are difficult to find globally. These rare materials are essential for creating advanced computer chips and targeted medical therapies.

A Look at the Financials

  • Revenue was $5.1 million for the three months ended June 30, 2026.
  • Net loss reached $34.1 million for the three-month period ended June 30, 2026.
  • Research and development expenses grew to $6.8 million in the second quarter of 2026.
  • Cash and cash equivalents totaled $219.6 million as of June 30, 2026.
  • Short-term investments were $35.3 million at the end of the second quarter of 2026.

Evolution of the Business

ASP Isotopes has transitioned from a development-stage company into a producer of advanced materials. Its expansion into gas production and pharmacy services provides a broader foundation for its core technology.

AI Generated • Aug 15, 2026

Industry

Chemicals

Sector

Materials

Employees

271

CEO

Paul E. Mann, CFA

Website

www.aspisotopes.com

Headquarters

Dallas, TX 75201, US

ASPI Financials

Key Financial Metrics (TTM)

Gross Margin

18.32%

Operating Margin

-312.31%

Net Income Margin

-428.00%

Return on Equity

-63.49%

Return on Capital

-13.61%

Return on Assets

-23.08%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$605.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

153.31M

Volume

2.38K

Avg. Volume

4.77M

Financials (TTM)

Gross Profit

$5.65M

Operating Income

-$96.35M

EBITDA

-$129.15M

Operating Cash Flow

-$66.68M

Capital Expenditure

-$15.77M

Free Cash Flow

-$82.46M

Cash & ST Invst.

$254.90M

Total Debt

$269.61M

Asp Isotopes Performance Analysis

Asp Isotopes annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 433,026N/A
20242024-12-31USD 4,144,226857.0%
20252025-12-31USD 23,849,000475.5%
Asp Isotopes sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30308.0%
Q42025-12-31240.7%
Q12026-03-31-74.9%
Q22026-06-3022.6%
Asp Isotopes annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.1481.4%
20232023-12-31USD -0.49257.7%
20242024-12-31USD -0.6328.1%
20252025-12-31USD -2.11234.4%
Asp Isotopes sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3085.4%
Q42025-12-31-460.0%
Q12026-03-3193.2%
Q22026-06-30-375.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$5.12M

+327.5%

Gross Profit

$1.48M

+158.7%

Gross Margin

28.89%

N/A

Market Cap

$605.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.23M

N/A

Employees

271

N/A

Net Income

-$33.59M

+55.3%

EBITDA

-$32.99M

+55.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$254.90M

+276.6%

Total Debt

$269.61M

+165.1%

Accounts Receivable

$4.59M

-85.2%

Inventory

$1.53M

+46.0%

Long Term Debt

$214.00M

+112.5%

Short Term Debt

$55.61M

+5523.4%

Return on Assets

-23.08%

N/A

Return on Invested Capital

-19.20%

N/A

Free Cash Flow

-$26.30M

-172.6%

Operating Cash Flow

-$22.21M

-181.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSMFerroglobe PLC
$3.85-4.94%
WLKPWestlake Chemical Partners LP
$21.53-0.87%
UAMYUnited States Antimony Corporation
$5.27-8.03%
BAKBraskem S.A.
$1.98-1.49%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$41.20+0.06%
MSTRStrategy
$112.39+0.08%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$17.55+0.11%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$122.21+0.01%

Questions About ASPI

What is the current price of Asp Isotopes?

Asp Isotopes is trading at $3.95 per share.

What is the 52-week range for Asp Isotopes?

Over the past 52 weeks, Asp Isotopes has traded between $3.51 and $14.49.

How much debt does Asp Isotopes have?

As of the most recent reporting period, Asp Isotopes reported total debt of $269.54M.

How much cash does Asp Isotopes have on hand?

Asp Isotopes reported $223.72M in cash and cash equivalents in its most recent financial results.

What is Asp Isotopes’s dividend yield?

Asp Isotopes does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services